Hemal Mehta

Hemal Mehta

University of Houston - Houston / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1631822
person_outline Hemal Mehta's MOST POPULAR ARTICLES
1-) Regression coefficient–based scoring system should be used to assign weights to the risk indexHB Mehta, V Mehta, CJ Girman, D Adhikari, ML JohnsonJournal of clinical epidemiology 79, 22-28, 20161252016
2-) Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort CollaborativeKM Andersen, BA Bates, ES Rashidi, AL Olex, RB Mannon, RC Patel, ...The Lancet Rheumatology 4 (1), e33-e41, 2022902022
3-) Risk factors associated with SARS-CoV-2 infections, hospitalization, and mortality among US nursing home residentsHB Mehta, S Li, JS GoodwinJAMA network open 4 (3), e216315-e216315, 2021662021
4-) The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with …M Sharma, HM Holmes, HB Mehta, H Chen, RR Aparasu, YCT Shih, ...Cancer 125 (7), 1155-1162, 20191032019
5-) Comparison of comorbidity scores in predicting surgical outcomesHB Mehta, F Dimou, D Adhikari, NP Tamirisa, E Sieloff, TP Williams, ...Medical care 54 (2), 180-187, 20161012016